An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)
Clinical trial NCT06315556 · RECRUITING
Trial details
- NCT number
- NCT06315556
- Sponsor
- Bayer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-05
- Primary completion
- 2027-03-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.